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ABSTRACT 
 
Ankylosing spondylitis (AS), an autoinflammatory disease, has been associated with impaired 
Endoplasmic reticulum aminopeptidase (ERAP) 1 activity, which is involved in priming antigenic peptides. 
The purpose of this study was to evaluate if the genetic variant of ERAP1 gene could impress the 
inflammation status of the AS patients. 
For genotyping, 140 AS cases and 140 healthy controls were enrolled. After isolation of peripheral 
blood mononuclear cells (PBMCs) and DNA extraction, all the subjects were genotyped for rs27044 
polymorphism using SSP-PCR assay. Total RNA of PBMCs was isolated, cDNA was synthesized, and 
quantitative analyses of mRNA expression of cytokines were performed via Real-time PCR using the SYBR 
Green Gene Expression MasterMix. To measure the concentration of cytokines in serum of subjects, 
ELISA was used. 
It was observed that the G allele of rs27044 polymorphism was significantly prevalent in AS patients. 
Moreover, the GG genotype and the GG+GC dominant model had significantly different distribution 
between study groups. There was a significant overexpression of mRNAs of IL-17A, IL-6, IL-33, TNF-α, 
and IFN-γ, while IL-10 was significantly downregulated in AS patients. The ELISA results were in line with 
that of the gene expression analysis. No significant differences in mRNA expression and concentration of 
cytokine were identified among AS patients with three genotypes for rs27044 SNP. 
This study replicated the association of polymorphisms in ERAP1 gene with the risk of AS in a 
population from Iranian. However, it did not directly determine the inflammatory profile of the AS 
patients. 
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INTRODUCTION 
 
Ankylosing spondylitis (AS), a type of 
spondyloarthropathies (SpA) group, is an inflammatory 
disorder, which is defined by major manifestations of 
sacroiliitis and axial inflammation. The prevalence of 
AS is approximately 0.1–1.4% in general and affects 
men more than women.
1
 It has been documented that 
the development of AS stems from a complicated 
interaction of environmental and genetic contributing 
factors.
2,3
 It has been identified that human leukocyte 
antigen (HLA)-B27 is one of the cogent genetic factors 
for AS; nonetheless, it can explain no further than 30 
percent of the total genetic risks of AS.
4
 As a 
consequence, a number of genes out of major 
histocompatibility complex (MHC) region is supposed 
to be involved in AS pathogenesis. According to 
previous studies, there have been accumulating results 
to suggest that non-MHC genes such as endoplasmic 
reticulum aminopeptidase (ERAP) 1, IL12B, interleukin 
23 receptor (IL-23R), and anthrax toxin receptor 2 
(ANTXR2) are attribute to AS susceptibility.
5,6
 
Ankylosing spondylitis is considered by aberrant 
regulatory pathways of inflammatory cytokines. 
Although the interleukin (IL)-17/IL-23 axis has 
repetitively been observed to be the important 
inflammatory player of AS, several inflammatory 
cytokines secreted from T helper (Th1) cells, for 
example interferon (IFN)-γ, IL-17A produced by Th17 
cells, and others like IL-6 and tumor necrosis factor 
(TNF)-α indicate increased levels in blood and joint 
milieu of AS patients. Along with this increase, a 
decreased level of immunosuppressive and 
immunoregulatory cytokines, including IL-10 and 
transforming growth factor (TGF)-β, has been reported. 
Other than Th cells, several types of immune cells like 
natural killer (NK) cells, type 3 innate-like 
lymphocytes (ILC3), macrophages, and etc., has been 
blamed as the culprit of inflammatory cytokine source 
in AS.
7-9
  
Arthritogenic peptide hypothesis has been 
supported by studies demonstrating an association 
between ERAP1 gene and AS risk. According to this 
hypothesis, AS is initiated when a peptide on the 
surface of antigen presenting cells (APCs) is presented 
by HLA-B27 molecules. As a result, AS has been 
underlying the diversity in the HLA-B27 peptide-
binding repertoire, which is attributed to variety in 
antigen-processing components, such as ERAP1 
enzyme.
4
 
ERAP1 belongs to the M1 family of zinc 
metallopeptidases, responsible for trimming peptides 
for HLA class I presentation
10
 and also cleave 
proinflammatory cytokine receptors (TNFR1, IL-1 RII 
and IL-6 Rα), eventuating in the downmodulation of 
their signal intensity on the cell surface.
11
 Recent 
findings have indicated association between single-
nucleotide polymorphisms (SNPs) in ERAP1 gene 
(rs27044) and AS.
12,13
 This relation was also confirmed 
by the studies performed in European and East Asian 
populations.
14,15 To gain a comprehensive 
understanding of the susceptibility variants in AS, the 
results replicated in other ethnic groups could be 
critical. 
ERAP1 is involved in impaired biology of antigen 
presentation in AS that could result in activation of 
immune cells to produce inflammatory cytokines.
7
 
Hence, in this study, we first attempted to evaluate the 
association between ERAP1 gene polymorphism 
(rs27044) and risk of AS in an Iranian population. In 
the next step, it was the purpose of this study to survey 
if the inflammatory profile of AS patients could be 
under impression of ERAP1 gene polymorphism. 
 
MATERIALS AND METHODS 
 
Patients and Healthy Controls Subjects 
This case-control study was done at the 
Immunology Research Center of Tabriz University of 
Medical Sciences in Iran between November 2015 and 
April 2017. All subjects submitted their written 
informed consent forms, and the Ethical Review Board 
centrally approved this study protocol in Tabriz 
University of Medical Sciences, Tabriz, Iran 
(Permission No. TBZMED.REC.1394.12937). The 
study group consisted of 140 Iranian patients with AS 
[120 (85.71%) males and 20 (14.29%) females, age 
range of range 23-62 years] and 140 healthy normal 
controls (Table 1). Examination of AS was based on 
the 1984 modified New York Criteria for AS and 
diagnosis was carried out by a qualified 
rheumatologist.
16
 The control group encompassed 140 
age, gender, and ethnically matched healthy individuals 
(85.71% males versus 14.29% females) without 
personal or family history of AS or other autoimmune 
diseases. The HLA-B27 status was determined in all of 
the participants. 
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Table 1. Demographic and clinical manifestations of ankylosing spondylitis patients and healthy individuals used for 
genotyping of ERAP1 gene rs27044 SNP and cytokine’s gene expression 
Characteristic AS Patients (n=140) Healthy controls (n=140) p value 
Age (years)  37.41±8.21 35.8±6.10 >0.05 
Female/Male, n (%) 20 (14.3%)/120 (85.7%) 20 (14.3%)/120 (85.7%) >0.05 
HLA-B27 positive, no (%) 111 (79.28%) 9 (6.4%) <0.05 
CRP (mg/L) 2.81±2.75 1.54±1.08 <0.0001 
Disease duration (years)  10.56±7.69 - - 
BASDAI score 4.52±2.34 - - 
BASFI score 3.25±2.33 - - 
BASG score 4.37±2.41 - - 
ASQoL score 7.25±4.74 - - 
AS; ankylosing spondylitis, HLA; human leukocyte antigen, CRP; C-reactive protein, BASDAI; bath ankylosing spondylitis disease activity index, 
BASFI; bath ankylosing spondylitis functional index, BASG; bath ankylosing spondylitis global score, ASQoL; ankylosing spondylitis quality of life 
 
 
Table 2. Sequence and amplicon size of the primers used for genotyping of ERAP1 gene rs27044 SNP and for quantification 
of cytokine’s mRNA expression in ankylosing spondylitis patients and healthy individuals 
SNP/Gene name Sequence of nucleotides (5′–3′) 
Amplicon 
Size (bp) 
Genotyping 
   rs27044 rs27044-G CACACAGGCGAGGAGTAGTAGATG 475 
rs27044-C CACACAGGCGAGGAGTAGTAGATC 
rs27044- Reverse GGTACTTGAGGAAGAGGCACAA 
   β-Actin ACTB Forward GGTCCTCACTGCCTGTCC 140 
ACTB Reverse CTCGTCATACTCCTGCTTGCT 
   HLA-B27 HLA-B27 Forward TACGTGGACGACACGCT 137 
HLA-B27 Reverse TGTGCCTTGGCCTTGC 
   Growth hormone GH1 Forward TGCCTTCCCAACCATTCCCTTA 434 
GH1 Reverse CCACTCACGGATTTCTGTTGTGTTTC 
mRNA expression 
   IL-37 Forward CCCAGTGCTGCTTAGAAGACC 173 
Reverse TGCTATGAGATTCCCAGAGTCC 
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   IL-33 Forward GAATCAGGTGACGGTGTTGATGG 81 
Reverse GTTGTTGGCATGCAACCAGAAG 
   IL-17A Forward CTCTGTGATCTGGGAGGCAAAG 196 
Reverse GACAATCGGGGTGACACAGG 
   IL-10 Forward AGCTGAGAACCAAGACCCAGAC 100 
Reverse AAGAAATCGATGACAGCGCC 
   IL-6 Forward AGCCACTCACCTCTTCAGAAC 117 
Reverse CCTCTTTGCTGCTTTCACAC 
   TNF-α Forward GCCCCAATCCCTTTATTACCC 72 
Reverse GCCCCCAATTCTCTTTTTGAGC 
   IFN-γ Forward GGCAGCCAACCTAAGCAAGA 222 
Reverse TTGGAAGCACCAGGCATGA 
   TGF-β Forward GCAACAATTCCTGGCGATACCT 115 
Reverse TCCCCTCCACGGCTCAAC 
   18srRNA Forward GATCAGATACCGTCGTAGTTCC 241 
Reverse CTGTCAATCCTGTCCGTGTC 
 
 
 
 
In this study, we applied Bath AS Disease Activity 
Index (BASDAI) and Bath AS Functional Index 
(BASFI) to assess the disease activity and physical 
function of the AS patients. Patients’ demographics, 
disease characteristics, including HLA-B27 status, age 
of symptom onset, BASFI, BASDAI, Bath AS 
Metrology Index (BASMI), Bath AS Global Score 
(BASG), and AS quality of life (ASQoL) were 
described with detail in Table 1. Five mL of peripheral 
blood was obtained from all the study subjects and the 
genomic DNA content from whole blood of AS 
patients and healthy controls was extracted exerting the 
QIAamp DNA Mini Kit (Qiagen, Germany). 
 
Primer Design 
ERAP1 gene sequence and data were obtained from 
the National Center for Biotechnology Information 
(NCBI), and Ensembl (http://asia.ensembl.org/) 
databases. For candidate non-synonymous coding SNP 
from ERAP1 gene, namely rs27044, and the related 
internal control gene (β-Actin) the primer pairs were 
designed applying the OLIGO7 Software, (Molecular 
Biology Insights, Inc., Cascade, CO., USA). Moreover, 
primers for HLA-B27 and the related internal control 
(Growth hormone 1) were obtained from already 
published works 
17
 and are listed in Table 2. 
In order to perform quantitative mRNA expression 
of the cytokines (IL-37, IL-33, IL-17A, IL-10, IL-6, 
TNF-α, IFN-γ, and TGF-β) as well as the 18srRNA as a 
housekeeping gene, primers (Table 2) were designed 
via Primer Express 3.0 (Applied Biosystems, Foster 
City, CA, USA). To determine the target specificity of 
primer pairs, they were checked by the Primer BLAST 
Tool of the National Center for Biotechnology 
Information (NCBI) website (http:// 
www.ncbi.nlm.nih.gov/tools/primer-blast/). Production 
of the primers was conducted by the custom 
oligonucleotide synthesis service (Metabion, 
Martinsried, Germany). 
 
Genotyping of ERAP1 Gene Polymorphism and 
HLA-B27 Detection 
The candidate non-synonymous coding SNP of 
ERAP1 gene, rs27044 (Gln730Glu), was genotyped by 
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Single Specific Primer-Polymerase Chain Reaction 
(SSP-PCR) assay (Figure 1.A). ―PCRBIO Taq Mix 
Red‖ (Biosystems, United Kingdom) was used for PCR 
amplification; PCR reactions were carried out in a total 
volume of 25 μL, with the initial denaturation step of 1 
min at 94°C, followed by 40 cycles at 94°C for 15s, 
annealing at 63 °C for 15s and extension at 72 °C for 
30s. HLA-B27 typing (Figure 1.B) was done using 
amplification PCR. PCR reactions were carried out in a 
total volume of 25 μL, with an initial denaturation step 
of 1 min at 94°C, followed by 40 cycles at 94°C for 
15s, annealing at 60°C for 15s and extension at 72°C 
for the 30s. Electrophoresis was carried out on a 2% 
agarose gel. The rate of a genotypes was evaluated by 
direct counting. 
 
 
 
Figure 1. A. Electrophoresis gel imaging for detection of HLA-B27 and ERAP1 gene rs27044 polymorphism after PCR 
amplification in DNA samples from ankylosing spondylitis patients and healthy subjects. The detection of genotypes was 
conducted based on the presence of bands in each lane for G (475 bp) and C (475bp) alleles (the band of internal control, β-
Actin, was also demonstrated as 140 bp). B. HLA-B27-related band (137 bp) and the internal control (growth hormone 1 
(GH1); 434 bp) are depicted. 
 
PBMC Isolation, RNA Extraction, and cDNA 
Synthesis 
Peripheral blood mononuclear cells (PBMCs) were 
isolated from fresh whole blood tubes containing 
EDTA. After diluting with PBS, samples were 
underlaid using Ficoll/Hypaque 1.077 g/mL 
(Lymphodex, inno-Train, Kronberg, Germany) density-
gradient centrifuged to isolate PBMCs and immediately 
stored at -80°C until use. RNA extraction from PBMCs 
was performed using Trizol total RNA extraction kit 
(GeneAll, Korea) according to company’s guidelines. 
The synthesize of the complementary DNA (cDNA) 
from the RNA of cells was carried out using the 
BioFact™ RT Series cDNA Synthesis Kit (Daejeon, 
Korea) according to the manufacturer’s protocol. 
Reverse transcription for cDNA production was 
conducted with the final volume of 20 µL pre tube. 
First, 4 µL of isolated RNA (30 µg) was mixed with 1 
µL of random hexamer primer and 7 µL of RNase-free 
H2O and then incubated at 65C for 5 minutes. Then, 
microtubes were chilled on ice, followed by adding a 
mixture of reaction buffer 4 µL, RNASe inhibitor 1 µL, 
dNTP mix 2 µL and reverse transcriptase 1 µL. 
Samples were then passed an incubation process at 
25C for 5 minutes followed by 42C for 60 minutes; 
the reaction was finished by heating at 70C for 5 
minutes.  
 
Real-Time Gene Expression Analysis 
Quantitative analyses of mRNA expression of the 
cytokines were carried out by Real-time PCR by the 
SYBR Green PCR Master Mix and Rotor-Gene Q 
Real-time PCR System machine (Qiagen, USA). 
Among the 140 AS and healthy subjects, mRNA 
expression analysis was conducted on 75 individuals 
from each group. The content of each reaction mixture 
in a total volume of 25 μL was master mix 12.5 μL, 
cDNA 4.5 μL, forward and revers primer 1 μL each, 
and H2O 6 μL. The PCR conditions were as follows: 50 
°C for 2 minutes, 95 °C for 10 minutes, then 40 cycles 
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of 95°C for 30 seconds, 60°C 30 seconds, and 72°C for 
30 seconds. The comparative CT method was applied to 
calculate the relative gene expression as described by 
Schmittgen and Livak.
18
 Relative amount of target 
cytokine mRNAs was normalized to the corresponding 
18srRNA mRNA level as the housekeeping gene. The 
relative expression for each sample was measured 
using the 2
−Ct
 equation. 
 
Cytokine Levels in Serum and ELISA 
In order to measure the cytokine levels of IL-17A, 
TNF-α, IFN-γ, IL-6, IL-33, IL-37, IL-10, and TGF-β in 
the serum samples of AS and healthy control groups, 
enzyme linked immunosorbent assay (ELISA) was 
conducted by commercial kit, provided by Invitrogen 
(Thermo Fisher Scientific, San Diego, CA, USA) 
 
Statistical Analysis 
Analysis of data was conducted by SPSS version 
24.0 for Windows (IBM Corp., Armonk, N.Y., USA). 
Data were expressed as either in percentage or mean ± 
standard deviation (SD). Demographic and clinical 
manifestations of the study population were assessed 
by descriptive statistical analysis. For evaluating the 
normality distribution of data, the Kolmogorov-
Smirnov test was used. To compare the clinical data, 
mRNA expression, and cytokine levels among patients 
with three different genotypes, the Kruskal-Wallis test 
was applied. To compare the mRNA expression level 
of cytokines as well as their level in serum, Mann-
Whitney U-test was performed. The associations 
between AS and ERAP1 gene SNP were analyzed by 
Logistic Regression and Pearson’s chi square (χ2) to 
evaluate for significance differences of both allele and 
genotype frequencies between patients and controls. 
Odds ratios (OR) and confidence intervals (95% CI) 
were employed for estimating the risk. P values were 
adjusted by Benjamini-Hochberg Method and regarded 
statistically significant if they were less than 0.05. 
Adherence to the Hardy–Weinberg Equilibrium (HWE) 
was measured using χ2 test in Package ―genetics‖ of R 
Software.  
 
RESULTS 
 
Demographic and Laboratory Data 
Demographic, laboratory, and clinical specifications 
of the patients are summarized in Table 1. Most 
importantly, 111 cases (79.28%) in AS group and 9 
cases (6.4%) in healthy control group were HLA-B27 
positive. Moreover, CRP level was significantly 
(p<0.0001) higher in AS cases in comparison to the 
controls (2.81±2.75 vs. 1.54±1.08).  
 
Allele and Genotype Frequencies 
The distribution of the genotypes for rs27044 SNP 
in healthy individuals did not indicate significant 
deviation from the HWE (p=0.35, Table 3). According 
to Table 3, the global major C allele was considered as 
the reference allele for rs27044 SNP according to SNP 
database of NCBI (https://www.ncbi.nlm.nih.gov/snp). 
The G allele of this SNP was observed more frequently 
in AS patients relative to the controls (45.71% vs. 
34.29%). This allele had significantly different 
distribution between AS patients and healthy subjects 
and increased risk of the disease (OR=1.61, 95% bCI= 
1.14-2.26; p=0.0059). The CC genotype was the 
reference and the GG genotype was prevalent in AS 
group (24.28% vs. 13.57%). This genotype increased 
the risk of AS (OR=2.45, 95% CI=1.24–4.82; 
p=0.0096). The frequency of GC genotype was higher 
in the AS patients than in healthy controls (42.86% vs. 
41.43%) and the frequency difference was not 
statistically significant (OR=1.41, 95%CI=0.83–2.39; 
p=0.192). As the dominant genotype, the GG+GC 
pattern indicated significantly different frequency 
between the two study groups (67.14% vs. 55%; 
OR=1.67, 95% CI=1.02–2.71; p=0.037). 
 
Association between demographic and clinical data 
and genotypes 
The relation of clinical data, including disease 
duration, CRP levels, BASDAI, BASFI, BASG, and 
ASQoL scores with the genotypes of ERAP1 gene 
rs27044 SNP are represented in Table 4. There was a 
statistically significant difference in disease duration 
(p<0.0001), CRP level (p=0.019), BASFI score 
(p=0.041), and ASQoL (p<0.0001) among AS patients 
with three genotypes of GG, GC, and CC. 
 
Gene Expression Analysis 
Among the evaluated cytokines, the mRNA 
expression of IL17A, IL-6, TNF-α, IFN-γ, and IL-10 
demonstrated significant difference between cases and 
controls (Figure 2). It was observed that IL17A (Fold 
change=2.33, p=0.0009, Figure 2. A), TNF-α (Fold 
change=2.68, p<0.0001, Figure 2. B), IFN-γ (Fold 
change=1.55, p=0.033, Figure 2. C), IL-6 (Fold 
change=1.96, p=0.0023, Figure 2. D), and IL-33 (Fold 
change=4.83, p=0.0001, Figure 2.E) demonstrated 
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significant upregulation in the PBMCs of AS patients 
compared with that of healthy subjects. Nonetheless, 
upregulation of IL-37 (Fold change=1.13, p=0.47, 
Figure 2.F) mRNAs in PBMCs of AS patients was not 
statistically significant in comparison to healthy 
controls. On the other hand, IL-10 mRNA level was 
downregulated significantly (Fold change=0.5, 
p=0.046, Figure 2.G) in PBMCs of AS patients than 
healthy subjects. 
Moreover, TGF-β demonstrated downregulation in 
AS patients in comparison to healthy individuals; 
however, the difference was not statistically significant 
(Fold change=0.76, p=0.42, Figure 2.H). 
mRNA expression of cytokines was also evaluated 
among AS patients with GG, GC, and CC genotypes 
for rs27044 SNP of ERAP1 gene. Data demonstrated 
insignificant differences of mRNA expression of all 
cytokines in AS cases with three genotypes for rs27044 
SNP (Figure 3). 
 
Table 3. Allele and genotype frequencies of ERAP1 gene rs27044 SNP in ankylosing spondylitis patients and healthy control 
group and related association analyses  
SNP* 
Allele 
/Genotype 
AS* (n=140) 
N% 
Control (n=140) 
N% 
OR* (95% CI*) p Adjusted P** 
rs27044 G 128 (45.71%) 96 (34.29%) 1.61 (1.14 - 2.26) 0.0059 0.019 
C (Reference) 152 (54.29%) 184 (65.71%) - -  
GG 34 (24.28%) 19 (13.57%) 2.45 (1.24 – 4.82) 0.0096 0.019 
GC 60 (42.86%) 58 (41.43%) 1.41 (0.83 – 2.39) 0.192 0.192 
GG+GC 94 (67.14%) 77 (55%) 1.67 (1.02 – 2.71) 0.037 0.049 
CC (Reference) 46 (32.86%) 63 (45%) - -  
HWE   P=0.35    
*SNP; single nucleotide polymorphism, AS; ankylosing spondylitis, OR; odds ratio, 95% CI; 95% confidence interval, HWE; Hardy-Weinberg 
equilibrium,  ** P values for the comparison of both allele and genotype frequencies were adjusted by Benjamini-Hochberg method 
The associations between AS and ERAP1 gene SNP were analyzed by Logistic Regression and Pearson’s chi square (χ2) 
 
 
 
Table 4. Association of ERAP1 gene rs27044 SNP with clinical manifestations of ankylosing spondylitis patients  
Characteristic rs27044 (GG) rs27044 (GC) rs27044 (CC) p  
Disease duration (years) 12.72±3.47 10.24±5.33 9.75±7.36 <0.0001 
CRP (mg/L) 3.97 ±2.88 3.31±3.55 1.72±0.97 0.019 
BASDAI score 5.11±3.09 4.25±1.71 4.26±1.75 0.428 
BASFI score 3.34±2.79 2.51±2.02 3.35±1.48 0.041 
BASG score 5.19±3.16 4.36±2.09 4.97±1.32 0.344 
ASQoL score 7.26±6.05 5.39±4.61 8.11±3.46 <0.0001 
CRP; C-reactive protein, BASDAI; bath ankylosing spondylitis disease activity index, BASFI; bath ankylosing spondylitis functional index, BASG; 
bath ankylosing spondylitis global score, ASQoL; ankylosing spondylitis quality of life 
The Kruskal-Wallis test was used to compare the characteristics among subjects harboring different genotypes 
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Cytokine Levels in Serum 
The results of cytokine concentration in serum of 
study participants were in accordance with that of 
mRNA expression (Figure 4). Levels of IL17A (45 
vs.23; p<0.0001, Figure 4. A), TNF-α (135.2 vs.48.5; 
p<0.0001, Figure 4. B), IFN-γ (153.8 vs. 119.4; 
p=0.0098, Figure 4. C), IL-6 (8.6 vs.2.85; p=0.0021, 
Figure 4. D), and IL-33 (206.1 vs. 133.7; p=0.0004, 
Figure 4. E) were increased significantly in serum 
samples of AS patients than controls, while IL-10 
(2.367 vs. 4.389; p=0.0035, Figure 4. G) showed a 
significantly decreased level. Level of IL-37 was 
increased (137 vs.124.1; p=0.39, Figure 4. F) and TGF-
β level was decreased (20.5 vs.24.4; p=0.15 Figure 4. 
H), but both insignificantly. 
Evaluation of cytokine levels in serum samples 
among AS subjects with three genotypes rs27044 SNP 
of ERAP1 gene indicated no significand differences 
(Figure 5). 
 
 
 
Figure 2. Demonstration of mRNA expression of cytokines in peripheral blood mononuclear cells (PBMCs) between 
ankylosing spondylitis patients and healthy subjects, as conducted by Real-time PCR gene expression analysis. The 
comparison was conducted by Mann-Whitney’s U-test (*demonstrates p<0.05, ** demonstrates p<0.01, *** demonstrates 
p<0.001, **** demonstrates p<0.0001). 
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Figure 3. Demonstration of mRNA expression of cytokines in peripheral blood mononuclear cells (PBMCs) between 
ankylosing spondylitis patients according to three genotypes (GG, GC, and CC) of ERAP1 gene rs27044 SNP. Real-time PCR 
was used to evaluate the expression of cytokine’s genes. The comparison was conducted by Kruskal-Wallis test. 
 
Figure 4. Bar graphs illustration of cytokine concentration in serum of ankylosing spondylitis and healthy control groups. 
The Enzyme-linked immunosorbent assay (ELISA) was used to evaluate the cytokine’s levels. The comparison was conducted 
by Mann-Whitney’s U-test (*demonstrates p<0.05, ** demonstrates p<0.01, *** demonstrates p<0.001, **** demonstrates 
p<0.0001). 
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Figure 5. Bar graphs illustration of cytokine concentration in serum of ankylosing spondylitis subjects based on three 
genotypes (GG, GC, and CC) of ERAP1 gene rs27044 SNP. The Enzyme-linked immunosorbent assay (ELISA) was used to 
evaluate the cytokine’s levels. The comparison was conducted by Kruskal-Wallis test. 
 
DISCUSSION 
 
Ankylosing spondylitis is defined as an 
inflammatory rheumatic disease of the axial skeleton 
that mainly impress young males. Despite greatest 
genetic risk of AS has been attributed to the MHC class 
I allele HLA‑ B*27, GWASs have disclosed more than 
60 further risk factors for this disease. Among these 
genetic risk factors, ERAP1 polymorphisms has been 
among the initial non-MHC loci identified with 
susceptibility to AS. In this replication study, we 
evaluated possible associations of rs27044 
polymorphism with the risk of AS in Iranian population 
in 140 AS cases and 140 healthy subjects and tried to 
discover if these variants affect the inflammatory 
profile of AS subjects. Our investigations resulted in 
identification of association of rs27044 SNP with AS 
and this variation affected the clinical picture of AS. 
However, this variation did not impress the 
inflammatory profile of the AS subjects. 
Over the course of past few decades, the genetic 
risk of AS has been extensively investigated in various 
populations.
2
 Numerous studies have reported that 
HLA-B27 is the major gene associated with AS with 
almost 95% of patients positive for this gene.
4
 
Nonetheless, only about 5% of subjects carrying the 
HLA-B27 gene has AS, suggesting that other genes, in 
addition to HLA-B27, also participate in disease 
proneness. Results from twin and familial studies of AS 
have established that HLA-B27 gene is responsible for 
only less than 50% of the total disease risk.
19,20
 Up until 
now, genome-wide and replication studies have 
revealed new genes associated with AS.
14,21
 
It has been reported that four aminopeptidase 
enzymes, encoded by genes located in the two loci on 
the chromosomes 5p15 and 17q21, has been associated 
with AS risk. ERAP1 and ERAP2 are encoded by 
genes harbored on the chromosome 5p15.
22
 In fact, 
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ERAP1 was the first aminopeptidase that was 
associated with AS.
14
 Until now, the association of 
ERAP1 has been extensively replicated in many 
studies, indicating similar allelic, genotypic, and 
haplotypic associations in various populations like 
white European and East Asian populations. This 
observation implies to involvement of common variants 
in AS pathogenesis across different ethnicities.
4
  
ERAP1 participates in processing of peptide 
antigens for presenting by MHC class I molecules for T 
lymphocytes by trimming N-terminally extended 
peptides to the proper final antigenic epitopes.
23
 
ERAP1 peptidase activity has been investigated in vitro 
to reveal if ERAP1 gene polymorphisms impress it. 
These studies have reported that the two protective 
polymorphisms, namely rs30187 and rs17482078, 
result in a 40% decreased in peptidase function of 
ERAP1.
24
 Wild type ERAP1 protein carrying rs27044 
variant was compared with recombinant ERAP1 and 
demonstrated that the functional circumstances of 
ERAP1 due to these variant were under the impression 
of substrate composition and concentration.
25
  
The first replication study of ERAP1 gene 
polymorphisms indicated association of rs30187, 
rs27434, and rs13167972 genotypes and haplotypes 
with AS susceptibility.
26
 This was the second 
replication study of ERAP1 gene variants in Iranian AS 
population. Although, we did not evaluate the 
association of those polymorphisms, but it was 
observed in this study that the G allele and GG 
genotype of rs27044 SNP was associated significantly 
with increased risk of AS. This may imply that ERAP1 
gene needs to be extensively studied in Iranian AS 
population that my result in identification of new 
variants with significant association. On the other hand, 
a meta-analysis of ERAP1 genetic polymorphisms 
indicated that the ERAP1 gene rs27044, rs17482078, 
rs10050860, rs30187, and rs2287987 SNPs were 
associated with the risk of AS in European population. 
Moreover, the minor allele G of ERAP1 gene rs27044 
were significantly associated with AS risk in European 
and Asians.
27
 It seems that rs27044 SNP is a risk 
variant for AS in these two populations. 
A number of studies have tried to disclose the 
correlation of genetic polymorphisms with clinical 
manifestations of AS patients. It has been reported that 
modified Stoke Ankylosing Spondylitis Spine Score 
(mSASSS) is under the impression of ERAP1 gene 
rs30187 and LMP2 gene rs17587 polymorphisms. 
Furthermore, disease duration, sex, and the LMP2 
rs17587 SNP were associated significantly with the 
baseline mSASSS, which indicates the radiographic 
severity in AS patients.
28
 Here, we noticed that 
different genotypes of rs27044 could impress the 
BASFI score and ASQoL in AS patients. To 
prematurely conclude, the genotypes of this 
polymorphism may impress the somehow the 
functional limitation of body movement. This, in turn, 
may result in decreasing the quality of life in long-time 
period. This hypothesis requires long-term monitoring 
of AS cases in large cohorts.  
ERAP1 participates in AS pathogenesis by altering 
the structure of HLA-B27 molecule.
24
 In fact, genetic 
polymorphisms of ERAP1 modulate the length and 
sequence of peptides that bind HLA-B27.
29,30
 
Unconventional types of HLA‑ B27, like free heavy 
chains (FHCs) can be accumulated in the gut and 
synovial tissues from spondyloarthritis (SpA) 
patients.
31
 In cellular perspective, FHCs are 
accumulated within the endoplasmic reticulum (ER), 
culminating in ER stress. This event, in turn, results in 
unfolded protein response (UPR). Pathogenesis of AS 
has been attributed to UPR, since it causes 
inflammatory responses with promoted production of 
cytokines, especially those found in IL-17/IL-23 axis, 
which is a critical pathway in the etiopathogenesis of 
AS.
32
 Dimers of HLA-B27- FHC promote IL-17 
production through inducing IL-23 receptor (IL-23R)-
positive T cells that express the killer cell 
immunoglobulin-like receptor (KIR) 3DL2 by FHCs 
expressed on the surface of antigen-presenting cells 
(APCs).
33
 We tried to evaluate if the genetic variants of 
ERAP1 gene could impress the inflammatory setting in 
AS patients. Although the inflammatory IL-33, IL-17A, 
IL-6, TNF-α, as well as IFN-γ cytokines demonstrated 
increased levels in AS patients relative to healthy 
controls (as well as significant decreased level of 
immunosuppressive IL-10 cytokine), none of the 
genotypes of the AS associated SNP (rs27044) had 
different expression and concentration levels in 
comparison to other genotypes. This may due to 
association of ERAP1 SNPs with the disease risk in AS 
subjects carrying HLA‑ B27,34 as we did not 
distinguish AS patients in terms of HLA-B27 status 
when performed cytokine level analysis. 
In consideration of all, this was the second 
replication study of ERAP1 gene polymorphism with 
AS susceptibility in Iranian population. We identified 
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another risk allele for AS in this population, in which 
the G allele and GG genotype of rs27044 increased the 
risk of AS. The genotypes of this SNP influenced the 
clinical manifestation of AS patients. In spite of 
increased inflammatory cytokines of IL-17A, TNF-α, 
IL-6, and IL-33 in AS patients in comparison to healthy 
controls, genotypes of rs27044 SNP did not impress the 
inflammatory cytokine profile of AS subjects. This 
could illuminate further aspects of AS etiopathogenesis 
and, ultimately, we will be armed with more 
apprehensive knowledge to design much optimal 
diagnostic and therapeutic tools. Nonetheless, as the 
limitation of the current study, it is recommended to 
perform further investigations using large sample sizes 
as well as evaluation other pathways along with 
ERAP1 that may affect the inflammatory state in AS 
patients. 
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